Johnson & Johnson’s attempt to develop a $5 billion-a-year Alzheimer’s disease drug has been rocked by a phase 2 flop. A scheduled data review found the anti-tau antibody posdinemab failed to ...

Kenyan legend Dennis Oliech has launched a scathing attack on national team head coach Benni McCarthy over his decision to drop Michael Olunga in the latest squad. The Harambee Stars will play two ...

Olunga was left out ahead of Kenya fixtures against Equatorial Guinea and Senegal.FKF Media. Kenyan legend Dennis Oliech has taken issue with national team Harambee Stars technical bench for leaving ...

McCarthy has changed Kenya's fortunes since taking over in March 2025, winning six of his 13 games in charge, which included a strong quarter-final showing at the African Nations Championships (CHAN).

Despite not being called up for the upcoming friendly games, talismanic striker Michael Olunga is still motivated to give his all to Kenya and break the national team's goalscoring record. Flashscore ...

Researchers have discovered that newborns have high levels of the tau protein, which is elevated in older people with Alzheimer’s disease, but that it causes them no harm. The discovery opens the door ...

Michael Olunga, the captain of Kenya's national football team Harambee Stars, has officially confirmed his departure from Qatari side Al Duhail SC, ending a successful four-and-a-half-year spell with ...

Researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of pathological tau after demonstrating that this vaccine generated a robust immune response in ...

An installation view of “Tau Lewis: Spirit Level” at David Zwirner Los Angeles. Photo by Elon Schoenholz / Courtesy David Zwirner For her debut show with David Zwirner, Tau Lewis transformed the Los ...

A biomarker test identified tau pathology in Alzheimer's disease before fibrillary tangles developed. Neurofibrillary tangle formation can be prevented by targeting intermediate soluble tau assemblies ...

Rahul Sidhu does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

While anti-tau antibodies are beginning to look promising (see previous story), small molecules that modify tau proteins haven’t yet fared well in clinical trials. At the 16th Clinical Trials on ...